Details
Stereochemistry | ACHIRAL |
Molecular Formula | 3S.2Sb |
Molecular Weight | 339.715 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[S--].[S--].[S--].[Sb+3].[Sb+3]
InChI
InChIKey=NVWBARWTDVQPJD-UHFFFAOYSA-N
InChI=1S/3S.2Sb/q3*-2;2*+3
Molecular Formula | Sb |
Molecular Weight | 121.76 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HS |
Molecular Weight | 33.073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Evaluation of fuadin therapy in schistosomiasis japonica. | 1951 Apr |
|
Laboratory studies on the joint effects of certain tris (p-aminophenyl) carbonium salts and antimonials as antischistosomal drugs. | 1965 |
|
Current chemotherapy of schistosomiasis japonica in the Philippines. | 1976 Jun |
|
[Substantiation of maximum permissible levels of antimony trioxide and pentasulide in the atmospheric air of inhabitated places]. | 1989 Apr |
|
Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni. | 1996 Oct 30 |
|
Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets. | 2010 Jul 19 |
|
Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes. | 2012 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 17:23:33 UTC 2022
by
admin
on
Fri Dec 16 17:23:33 UTC 2022
|
Record UNII |
F79059A38U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1345-04-6
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
DTXSID6030732
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
1316091
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | RxNorm | ||
|
SUB51532
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
1604
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
F79059A38U
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
F79059A38U
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
9862749
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
215-713-4
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
C064234
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
SUB125764
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
Antimony trisulfide
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
CONCEPT | Industrial Aid | ||
|
C142927
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | |||
|
M1971
Created by
admin on Fri Dec 16 17:23:33 UTC 2022 , Edited by admin on Fri Dec 16 17:23:33 UTC 2022
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY | |||
|
ACTIVE MOIETY |